Block Listing Application

RNS Number : 4715E
Knights Group Holdings PLC
07 July 2021
 

7 July 2021

Knights Group Holdings plc

 

("Knights", the "Company" or the "Group")

 

Block Listing Application

 

Knights,  the UK's fastest growing legal and professional services business 1 , announces that a block listing application has been made for a total of 1,400,000 new ordinary shares of 0.2 pence each ("New Shares") to trading on AIM.

 

The New Shares are to be block listed pursuant to the Employee Share Options and Incentives Plan. Admission is expected to become effective at 8.00am on 9 July 2021. The shares will be issued fully paid from time to time and will rank pari passu in all respects with the existing issued ordinary shares of the Company.

 

As at today, Knights has 83,454,465 ordinary shares in issue. The Company will notify on a quarterly basis when there are changes to the issued share capital, and these quarterly figures may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change in their interest in, the Company under the FCA's Disclosure and Transparency Rules.

 

Ends

 

 

Notes

1 Ranked number one for revenue growth over the last four years in the recently published Lawyer's Top 100 Survey

 

 

Enquiries 

 

Knights

David Beech, CEO

via MHP Communications

Numis (Nominated Adviser and Broker)

Stuart Skinner, Kevin Cruickshank, George Shiel

+44 20 7260 1000

MHP Communications (Media enquiries)

Andrew Jaques, Katie Hunt, Rachel Mann

+44 20 3128 8794

knights@mhpc.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ALSFIFFADSIDIIL
UK 100

Latest directors dealings